S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(0.35%) $78.38
Gas
(0.33%) $2.15
Gold
(0.50%) $2 320.10
Silver
(1.65%) $27.13
Platinum
(-0.23%) $963.05
USD/EUR
(0.00%) $0.929
USD/NOK
(-0.10%) $10.86
USD/GBP
(0.00%) $0.797
USD/RUB
(0.00%) $91.45

Sanntidsoppdatering for Annovis Bio Inc [ANVS]

Børs: AMEX Industri: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 0.00%

Sist oppdatert3 mai 2024 @ 22:00

-4.95% $ 5.18

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):
Profile picture for Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders...

Stats
Dagens volum 609 601
Gjennomsnittsvolum 452 166
Markedsverdi 57.04M
EPS $0 ( 2024-04-01 )
Neste inntjeningsdato ( $-0.870 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.830
ATR14 $0.0190 (0.37%)
Insider Trading
Date Person Action Amount type
2023-11-20 White Mark K. Buy 1 990 Common Stock
2023-11-20 Mccarthy Reid Buy 0 Common Stock
2023-11-20 Hoffman Michael B Buy 163 880 Common Stock
2023-11-20 Maccecchini Maria-luisa Buy 40 970 Common Stock
2023-11-20 Hagopian Henry Iii Buy 820 Common Stock
INSIDER POWER
90.09
Last 98 transactions
Buy: 4 567 241 | Sell: 3 252 094

Volum Korrelasjon

Lang: -0.23 (neutral)
Kort: 0.27 (neutral)
Signal:(44.051) Neutral

Annovis Bio Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Annovis Bio Inc Korrelasjon - Valuta/Råvare

The country flag 0.84
( strong )
The country flag 0.82
( strong )
The country flag 0.00
( neutral )
The country flag 0.77
( moderate )
The country flag -0.81
( strong negative )

Annovis Bio Inc Økonomi

Annual 2023
Omsetning: $0
Bruttogevinst: $0 (0.00 %)
EPS: $-6.23
FY 2023
Omsetning: $0
Bruttogevinst: $0 (0.00 %)
EPS: $-6.23
FY 2022
Omsetning: $0
Bruttogevinst: $0 (0.00 %)
EPS: $-3.08
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-1.900

Financial Reports:

No articles found.

Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.